论文部分内容阅读
目的：观察经支气管动脉灌注化疗药物与全身化疗的优缺点，寻求治疗支气管肺癌的优化方法。方法：对30例支气管肺癌患者共60例次，经支气管动脉DSA，加抗癌药物灌泣。与30例支气管肺癌患者共40例次，用常规全身化疗后的疗效及副作用进行比较。了解这二种治疗方法的疗效及副作用。结果：二者疗效差异无显著性（P值＞0．05），但前者副作用明显较后者小。结论：经支气管动脉灌注在治疗肺癌，特别是对于一般情况较差的非小细胞肺癌的患者较全身化疗为优。
Objective: To observe the advantages and disadvantages of transbronchial arterial infusion chemotherapy and systemic chemotherapy, and to seek an optimized method for the treatment of bronchial lung cancer. Methods: A total of 60 patients with bronchial carcinoma were performed 60 times, and the bronchial arteries DSA plus anti-cancer drugs were soaked. A total of 40 cases with 30 patients with bronchial cancer were compared with the efficacy and side effects after routine systemic chemotherapy. Understand the efficacy and side effects of these two treatments. Results: There was no significant difference in efficacy between the two (P value>0.05), but the former had significantly less side effects than the latter. CONCLUSIONS: Transbronchial arterial infusion is superior to systemic chemotherapy in the treatment of lung cancer, especially in patients with poor general conditions of non-small cell lung cancer.